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Background: A severe MD was broken out at a farm in Shandong, China, despite FC126 vaccination of the
chickens at 1-day-old. The mortality of the flocks reached up to 38.3%. The infected chickens were found to have
MD pathological changes, including enlargement of spleens, livers and kidneys, and tumors occured on organs
later. Samples were collected from the chickens for diagnosis.
Methods: The collected samples were inoculated into primary duck embryo fibroblast (DEF) cells, and the MDV
strain named SD2012-1 was isolated. In order to identify the isolate, amplification by PCR and sequencing of
oncogenic Meq and vIL-8 gene were processed, the obtained sequences were compared with the sequences of
reference strains, and SD2012-1 was used to challenge immunized SPF chickens.
Results: A very virulent MDV isolate strain, SD2012-1, was isolated from a chicken flock in Shandong Province,
China, the isolate had the characteristics of very virulent MDV-1, nucleotide and deduced amino acid sequence
comparisons of Meq and vIL-8 gene of SD2012-1 with those of reference strains showed SD2012-1 had high
homology with MDV strains isolated from China, SD2012-1 could break through the protection provided by HVT
vaccine and HVT + SB-1 vaccine immunization and caused the mortality of SPF chickens over 60%. The immune
failure occured at the farm could be due to the improper selection of vaccines. SD2012-1 produced death later and
the gross postmortem lesions of chickens died early and later were different.
Conclusions: MDV strain SD2012-1 isolated from Shandong Province, China was found to have the characteristics
of very virulent MDV-1, which could break through the protection provided by HVT vaccine and HVT + SB-1 vaccine,
the virus seemed to have a long latent period, and cause different gross postmortem lesions of chickens between
chickens died early and later. A better immunization way should be chosen to prevent infection of this MDV strain
in field.
Keywords: Marek’s disease virus, Isolation, PCR, Oncogenic gene, Virulence, ImmunizationMarek’s Disease Virus (MDV) was an oncogenic poultry
herpesvirus, causing not only death of chickens directly,
but also immunosuppression of infected chickens sensi-
tive to other pathogens, MDV strains (MDVs) had be-
come increasingly virulent since the 1960s [1,2]. MDVs
were classified into three serotypes which had major dif-
ferences in genome and biological features. Serotype 1
MDVs included all the oncogenic strains and their attenu-
ated forms; serotype 2 MDVs were non-oncogenic viruses
isolated in chickens; serotype 3 MDVs were non-
oncogenic viruses isolated in turkey, generally known as* Correspondence: gzh1832@126.com
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reproduction in any medium, provided the orherpesvirus of turkey or HVT [3]. serotype 1 MDVs could
be further classified into four pathotypes, including mild
(m), virulent (v), very virulent (vv) and very virulent plus
(vv+) strains [4,5].
Control of Marek’s disease was predominantly via vac-
cination of chickens, three types of vaccine had been de-
veloped for use against MD. These were herpesvirus of
turkey (HVT), non-pathogenic serotype 2 MDV and
non-pathogenic serotype 1. In 1970s, HVT vaccine was
mainly used to control the disease. In mid-1980s, sero-
type 2 vaccine such as strain SB-1 was used in combin-
ation with HVT against the enhanced virulence strains.
With further increase in virulence of field viruses [6],
serotype 1 vaccine CVI988/Rispens [6,7] was introducedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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CVI988/Rispens vaccination had been reported, when
used either alone or in combination with serotype 2
and/or serotype 3 vaccines, suggesting the emergence of
high virulent strains [8,9].
In recent years, there were virulent MDVs circulating
in China, the mortality rate of MD could reach up to
15%-60%. Isolate of MDVs in China were reported in
breeder or layer flocks which had been vaccinated by
HVT or CVI988/Rispens [10-12], the isolates were high
pathogenic for chickens, the emergence of MDVs of in-
creasing virulence was a significant problem for the
poultry industry.Methods
Samples collection
A severe MD was broken out at a farm with 3000 chick-
ens in Shandong, China, despite FC126 vaccination of
the chickens at 1-day-old. The clinic symptoms and
death of MD in the chicken flocks began at about 60-
day-old and continued until 135-day-old, the mortality
of the flocks reached up to 38.3%. The infected chickens
were found to have MD pathological changes, including
enlargement of spleens, livers and kidneys, and tu-
mors occured on organs later. Heparinised blood sam-
ples were collected from chickens with tumor lesions for
diagnosis.
This experimental research on animals were performed
with the approval of Experimental Animal Administrative
Center of Shandong Province.Virus isolation
The collected samples were kept under refrigeration and
transported, lymphocytes separated from the blood sam-
ples by lymphocyte separation medium were inoculated
into primary duck embryo fibroblast (DEF) cells prepared
from 11-day-old embryonated eggs, the inoculated DEF
cells were incubated at 37°C with 5% CO2 for five days.
After 3 passages, typical cytopathic effect (CPE) of the in-
oculated DEF cells stabilized at 96 hrs after inoculation.
The MDV strain named SD2012-1 was obtained by isola-
tion, and the DEF cell cultures of SD2012-1 were collected





REV F: 5’-CATACTGGAGCCAATGGTGTAAAGGGCAGA-3’PCR amplification of oncogenic genes
The DNA of SD2012-1 as PCR templates was extracted
from inoculated DEF culture samples and tissue samples
with tumor lesions using mini-spin column chromatog-
raphy method. In brief, samples was treated using proteo-
lytic enzyme, then an equal volume of 100% ethanol was
added to the lysate and the DNA was purified by mni-spin
column chromatography. Contaminating proteins were
removed via ethanol/salt washes, and the DNA was eluted
for PCR.
The MDV target genes of PCR were Meq and vIL-8
gene, which were reported to have the greatest possibil-
ity being associated with viral oncogenicity and patho-
genicity [1]. Primers for Meq and vIL-8 gene had been
used to amplify the same genes of 18 MDV isolates from
China [11], the PCR product of Meq and vIL-8 gene of
SD2012-1 were produced individually by amplification
[11] of the virus DNA extracted from DEF cultures and
tissue samples infected with SD2012-1.
In order to verify the absence of infection of chickens
with avian leukosis virus (ALV) and reticuloendotheliosis
virus (REV), all the samples for amplification of MDV
Meq and vIL-8 genes were also detected by previously
reported PCR method for ALV [13] and REV [14].
The primers which had been used for PCR amplifica-
tion of MDV, ALV and REV were shown in Table 1.
DNA cloning and sequencing of SD2012-1 strain
The PCR products of Meq gene and vIL-8 gene of
SD2012-1, corresponding to the predicted size, were
purified from agarose gel, and were ligated with a TA
cloning vector pMD19-T, and then were transformed
into DH5a competent cell individually. The cloned Meq
and vIL-8 genes were then sequenced by Sanger dideoxy
sequencing method.
Comparison of Meq and vIL-8 gene of SD2012 with
reference strains
The obtained Meq and vIL-8 nucleotide sequence and
the deduced amino acid sequence of SD2012-1 were
compared with 20 reference MDVs for the homology
analysis with the use of MegAlign program. Among
these 20 reference strains, 3 strains were vaccine strains,
11 strains were isolated from China, and 6 strains wereEV
quence DNA sizes
R: 5’-GCATAGACGATGTGCTGCTGAG-3’ 1081 bp
R: 5’ -TAGACCGTATCCGTGCTCCATC-3’ 886 bp
R: 5’-AGTTGTCAGGGAATCGA-3’ 436 bp
R: 5’-AATGTTGTAGCGAAGTACT-3’ 291 bp
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of Meq genes, and 8 strains were used for comparison of
vIL-8 genes. The MDV reference strains were retrieved
from the GenBank database, and the backgrounds of
the reference strains used in this study were listed in
Table 2.
Virulence studies of SD2012-1
90 SPF chickens randomly divided into three groups were
vaccinated at the age of one day, In group 1, 30 chickens
were vaccinated with 2000 PFU HVT (FC126 strain, 2000
PFU HVT had been the suggested dosage used at the farm
with MD broken out); in group 2, 30 chickens were vacci-
nated with bivalent vaccine (2000 PFU FC126 + 1200 PFU
SB-1); in group 3, 30 chickens were inoculated with phos-
phate buffer. At the age of ten days, all the chickens were
challenged intra-abdominally with 0.5 ml diluent of plaque
purified SD2012-1 strain containing 4000 PFU. Clinical
signs and gross postmortem lesions were recorded after
virus challenge. Organs of chickens with lesions were
sampled for PCR diagnosis.
Results
PCR amplification for Meq and vIL-8 gene of SD2012-1
By PCR [11] of the extracted virus DNA with primers in
Table 1, the specific presence of an approximately 1081 bpTable 2 MDV reference strains published in GenBank
MDV strains Virulence Geographic origi
0093 High virulence Guangxi, China
0095 High virulence China
0297 High virulence China
0304 High virulence Guangxi, China
G2 High virulence Guangxi, China
GX070060 High virulence China
GX070079 High virulence China
GXY2 High virulence China
YLO40920 High virulence China
LS High virulence Sichuan, China
LMS High virulence Sichuan, China
3004 Vaccine strain Russia
814 Vaccine strain China
CVI988 Vaccine strain Netherland
CU-2 Mild virulence USA
GA virulence USA
Md5 Very virulenc e USA
RB1B Very virulence USA
648A Very virulence plus USA
584A Very virulence plus USA
“M” refers to accession number of Meq gene; “V” refers to accession number of vIL-long DNA product for MDV Meq gene (Figure 1-A) and
the specific presence of an approximately 886 bp long
DNA product for MDV vIL-8 gene (Figure 1-B) were
found in samples, including the DEF cultures infected
with SD2012-1 isolate, samples collected from chickens
infected with SD2012-1 at the farm and samples collected
from challenged chickens with SD2012-1, the PCR prod-
ucts from all the samples were obvious, which verified the
existence of infection with MDV to chickens and inocu-
lated DEF cells.
Detection of ALV and REV by PCR
All the samples, including the DEF cultures infected
with SD2012-1 isolate, samples collected from chickens
infected with SD2012-1 at the farm and samples col-
lected from challenged chickens with SD2012-1were
verified to be negative of Avian Leukosis virus (Figure 1-C)
and Reticuloendotheliosis virus (Figure 1-D) by PCR,
which showed the absence of ALV and REV in these
samples.
sequence of Meq and vIL-8 gene of SD2012-1
By sequencing, the nucleotide sequence of Meq and
vIL-8 gene of SD2012-1 and their deduced amino acid
sequence were obtained, the sequences of SD2012-1 were




















Before 2000 DQ534532(M, V)
8 gene; “N/A” refers to data not available.
Figure 1 Detection of MDV, ALV and REV by PCR. (A) PCR amplification of Meq gene; (B) PCR amplification of Vil-8 gene. (C) Detection of ALV
by PCR; (D) Detection of REV by PCR; (M) DL 2000 DNA Marker; (+) Positive control of ALV in (C) or REV in (D). (1) Spleen of infected chicken from
farm with MD broken out; (2) DEF culture infected with MDV SD2012-1; (3) Spleen of 55-day-old died chicken without tumor; (4) Spleen of 90-day
-old chicken with tumor; (5) DEF culture without infection.
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vIL-8 gene.
Sequence analysis of SD2012-1
Comparisons of Meq and vIL-8 gene of SD2012-1 with
those of reference strains showed SD2012-1 had high
homology with the reference strains.
Comparisons of the nucleotide sequence of Meq gene
of SD2012-1 with the sequence of 20 reference strains in
Table 2 showed the nucleotide homology of SD2012-1
isolate with the 20 strains was between 94.7-99.8%,
SD2012-1 had the highest homology with LS at 99.8%,
and had the lowest homology with CVI988 at 94.7%.
The Meq amino acid of SD2012-1 was 339aa long, com-
parisons of Meq protein amino acid sequence of SD2012-
1 with the sequence of 20 strains in Table 2 showed theFigure 2 Alignment for amino acid mutation site on Meq gene of 21amino acid homology of SD2012-1 isolate compared with
the 20 strains was between 96.5-99.4%, SD2012-1 had the
highest amino acid homology with LS at 99.4%, and had
the lowest homology with CVI988 at 96.5%. As most
strains isolated in China, SD2012-1 had the same amino
acid mutation of Meq protein (Figure 2) at position 71
(S to A), 77(K to E), 80(D to Y), 115(V to A), 119(R to C),
153(Q to P), 176(P to R) and 217(P to A ), except no
mutation of SD2012-1 at position 139(remain T).
Comparison of the nucleotide sequence of vIL-8 gene of
SD2012-1 with the sequence of 8 strains, CVI988, CU-2,
GA, RB1B, 648A, 584A, LS, LMS, showed the nucleotide
homology of SD2012-1 isolate with 8 reference strains
were between 99.4-99.6%, SD2012-1 had the highest hom-
ology with LS, RB1B and CU-2 at 99.6%, and had the low-
est homology with CVI988 and 584A at 99.4%.MDVs.
Figure 3 Alignment for amino acid mutation site on vIL-8 gene of 9 MDVs.
Gong et al. Virology Journal 2013, 10:155 Page 5 of 8
http://www.virologyj.com/content/10/1/155The amino acid of SD2012-1 was 134aa long, compari-
son of vIL-8 protein amino acid sequence of SD2012-1
with CVI988, CU-2, GA, RB1B, 648A, 584A, LS and LMS
showed that the amino acid homology of SD2012-1 isolate
with 8 strains was between 97.8-99.3%, SD2012-1 had the
highest homology with LS at 99.3%, and had the lowest
homology with CVI988 at 97.8%. The vIL-8 gene amino
acid sequence of CU-2, GA, RB1B, 648A, 584A were con-
servative without amino acid mutation between the 5
strains. As LS did, SD2012-1 had the same amino acid
mutation of vIL-8 protein (Figure 3) at position 4(L to S)
and 31(D to G) compared with CU-2, GA, RB1B, 648A,
584A .Virulence of SD2012-1
No clinical sign was observed during the first 6 week post
challenge of SD2012-1. The earliest death appeared on
45 days post challenge in no vaccine group, and on 48 days
post challenge in HVT immunized group and FC126 +
SB-1 group. The peak of death came on 60–85 days post
challenge. The mortality were 70.3% in no vaccine group,
66.7% in HVT immunized group and 60% in FC126 + SB-
1 immunized group (Table 3). Organic samples collected
from the chickens with lesions were detected to be MDV
positive by PCR (Figure 4). the main gross lesion of the
early died chickens were degeneration and swelling of or-
gans without development of tumor (Figure 5). The gross









no vaccine 30 9 13 22 (70.3%)
HVT 30 8 12 20 (66.7%)
HVT + SB1 30 8 10 18 (60%)developed on liver, heart and mesentery, and gizzard
swelling with thicken corneum layer which was easy to be
peeled (Figure 6).Discussion
In the past 40 years, the virulence of MDVs had been in-
creasing gradually, which was possibly caused by the se-
lective pressure of vaccination [5,15-18]. With isolation
and gene sequencing, the oncogenic gene changes
emerged in the predominant strains were monitored, and
the effectiveness of existing vaccines were evaluated [19],
both played an important role on MD prevention. In re-
cent years, MD occurred frequently in China in spite of
vaccination, a number of MDVs were isolated from differ-
ent area in China, molecular epidemiologic studies on the
amino acid sequences of oncogenic gene of MDVs indi-
cated that the amino acid mutations in Meq gene and vIL-
8 gene displayed perfect regularity in MDVs circulating in
China, which could be considered as features of field
MDVs prevalent in recent years in China [11,12,20].
In this study, a virulent MDV isolate which caused se-
vere death of chicken at the infected farm was isolated by
transfecting monolayer of duck embryo fibroblast (DEF)
with the peripheral blood lymphocytes (PBLs) of the
infected chicken, the MDV isolate strain named SD2012-1
was isolated from a chicken flock in Shandong Province,
China, which had been vaccinated with HVT vaccine, the
isolate was found to have the characteristics of virulent
MDV-1.
The oncogenic Meq gene and vIL-8 gene of SD2012-1
were amplified by PCR and sequenced. Compared with 20
reference strains, SD2012-1 had the highest Meq nucleo-
tide sequence homology with LS, a virulent strain isolated
from China, at 99.8%, and had the lowest nucleotide se-
quence homology with CVI988 at 94.7%. As most strains
isolated in China [11], the Meq amino acid of SD2012-1
was 339aa long, which was 59aa shorter than Meq protein
Figure 4 PCR amplification of Meq gene from tissues of chickens infected with SD2012-1. (1) Feather pulp; (2 ) liver; (3) kidney; (4) muscular
stomach; (5) mesentery; (6) duodenum; (7) heart; (8) bursa of Fabrius.
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insertion resulting suppression of Meq expression [21,22].
The Meq amino acid of SD2012-1contains a basic leucine
zipper (bZIP) domain at the N terminal closely resembling
the jun/fos oncogene family [23], SD2012-1 had the
highest Meq amino acid homology with LS at 99.4%, and
had the lowest amino acid homology with CVI988 at
96.5%. Like the 11 compared reference strains from China
in Table 2, SD2012-1 had the same amino acid mutation of
Meq gene at position 71 (S to A), 77 (K to E), 80 (D to Y),
115 (V to A), 119 (R to C), 153 (Q to P), 176 (P to R)
and 217 (P to A ), which displayed regularity of strains iso-
lated from China [11,12], except no mutation of SD2012-1
at position 139 (remain T no A), and threonine (T) was
also found in GA, Md5, RB1B, 648A, 584A strain at pos-
ition 139. It was reported that amino acid change at pos-
ition 77 (E to K) was the feature of high virulent MDV
strains, and a glutamic acid (E) at position 77 was associ-
ated with lower virulence [24], however, SD2012-1 and
the 11 compared reference strains from China had glu-
tamic acid (E) at position 77, and all the 12 MDV strains
from China were high virulence strains, this could demon-
strate that a glutamic acid (E) at position 77 was not nec-
essarily a feature of MDV strains of lower virulence. Like
mild virulence, virulence and very virulence referenceFigure 5 Pathological changes of chickens died at 55-day-old. (a) yello
surface; (c) bursa of Fabricius swelling; (d) muscular stomach swelling; (e) g
swelled spleen; (g) kidney swelling and pale in color.strains in Table 2, SD2012-1 had the amino acid of cyst-
eine(C) at position 119, whereas an arginine(R) to C muta-
tion at position 119 is found in US vv +MDVs 584A and
the 648A strain [11].
vIL-8 gene was reported to have possibility to be associ-
ated with viral oncogenicity and pathogenicity [25], Com-
paring SD2012-1 with 8 reference strains, CVI988, CU-2,
GA, RB1B, 648A, 584A, LS, LMS, showed SD2012-1 had
the highest vIL-8 nucleotide sequence homology with LS,
RB1B and CU-2 at 99.6%, and had the lowest nucleotide
sequence homology with CVI988 and 584A at 99.4%. The
amino acid of vIL-8 of SD2012-1 was 134aa long, the
amino acid homology of SD2012-1 isolate with 8 strains
was between 97.8-99.3%, SD2012-1 had the highest amino
acid homology with LS at 99.3%, and had the lowest
amino acid homology with CVI988 at 97.8%. The vIL-8
gene amino acid sequence of CU-2, GA, RB1B, 648A,
584A were conservative without amino acid mutation be-
tween the 5 strains. SD2012-1 had the amino acid muta-
tion of vIL-8 gene at position 4 (L to S) and position 31
(D to G) compared with CU-2, GA, RB1B, 648A, 584A. It
should be noticed that the amino acid mutations of vIL-8
of SD2012-1 at position 4 and position 31 were found in
most isolates from China [11], which displayed regularity
of strains isolated from China [11].w degeneration diffusely in liver edge; (b) rough and uneven in liver
landular stomach swelling; (f) lots of white diffused nodule in the
Figure 6 Pathological changes of chickens died at 90-day-old. a) diffused nodule in the thicken mesentery; (b) ulcer in duodenal mucosa; (c)
tumor in liver; (d) tumor in heart; (e) muscular stomach swelling with thicken corneum layer, and easy to be peeled.
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were widely used against Marek’s disease in China, HVT
was more often only used at farms for its easier storage
and usage than the others, this would result in the high
risks of infection with high virulent Marek’s disease
strains. The virulence study of SD2012-1 revealed that
SD2012-1 characterized very virulence to SPF chickens,
the isolate could break through the protection provided
by HVT vaccine and HVT + SB-1 vaccine immunization
and caused chicken mortality over 60%, it also revealed
that the immune failure occured at the farm was due to
the selection of HVT vaccination. We were taking another
experimental protection trial including vaccination with
CVI988 against SD2012-1, the study would be reported in
another paper.
Unlike LS strain isolated in Sichuan, China, which could
produced high early mortality and tumor in chicken
18 days post challenge [11], SD2012-1 seemed to have a
long latent period, it produced death later on 45 days post
challenge in no vaccine group, and 48 days post challenge
in HVT immunized group. The peak of death came on
60–85 days post challenge.
Gross postmortem lesions were found in chickens died
early with degeneration in liver, swelling of bursal and
gizzard, tumors were not found in early died chickens.
Although these lesions are atypical for MDV, the MDV
positive detection result (Figure 4) by PCR of the organswith atypical lesion for MDV confirmed their infection
with MDV. Typical MD lesion with gross tumor develop-
ment was found 75 days post challenge, 30 days after the
early death of MD was found, tumors could be found on
liver, heart and mesentery of the later died chickens, the
chickens were detected to be MDV positive by PCR.
Conclusion
In conclusion, a very virulent MDV isolate strain named
SD2012-1 was isolated from a chicken flock in Shandong
Province, China, which had been vaccinated with HVT
vaccine, the isolate was isolated by transfecting mono-
layer of duck embryo fibroblast (DEF).
SD2012-1 was found to have the characteristics of very
virulent MDV-1, SD2012-1 had the highest Meq amino
acid homology with LS at 99.4%, and had the lowest hom-
ology with CVI988 at 96.5%. SD2012-1 had the same
amino acid mutation of Meq gene at position 71, 77, 80,
115, 119, 153, 176 and 217, which displayed regularity of
strains isolated from China [11,12], except no mutation of
SD2012-1 at position 139aa.
SD2012-1 had the highest vIL-8 nucleotide sequence
homology with LS, RB1B and CU-2 at 99.6%, and had the
lowest homology with CVI988 and 584A at 99.4%.
SD2012-1 had the amino acid mutation of vIL-8 gene at
position 4 (L to S) and position 31 (D to G), which
displayed regularity of strains isolated from China [11].
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by HVT vaccine and HVT + SB-1 vaccine immunization
and caused chicken mortality over 60%, and the immune
failure occured at the farm could be due to the selection
of HVT vaccination.
SD2012-1 seemed to have a long latent period, it pro-
duced death later on 45 days post challenge in no vaccine
group, and 48 days post challenge in HVT immunized
group. The gross postmortem lesions of chickens chal-
lenged by SD2012-1 died early and later were different,
the main gross lesion of the early died chickens were de-
generation and swelling of organs without development of
tumor, and gross tumor lesion occurred in organs and tis-
sue was found later.
A better immunization way should be chosen to prevent
infection of this MDV strain in field.
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